ASX/OCC (ASX/OCC)

Australian Securities Exchange: ASX/OCC · AUD

A$0.54

+0.00 (+0.9%)· Recorded snapshot

Market cap	147.1M
Revenue (ttm)	11.4M
Net income (ttm)	-13.9M
EPS (ttm)	-A$0.05
Shares out	272.4M
Volume	362,148
Beta	-0.03

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 11.4M
Net income (ttm): -13.9M
EPS (ttm): -A$0.05
Market cap: 147.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-56.8

P25 n/aP50 n/aP75 n/a

ROIC-45.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/OCC indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

AUD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-10-22
Enterprise value	AUD 104.1M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2006
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000OCC6
Last earnings date	2026-10-22
Last refreshed	2026-10-28
Market cap	AUD 147.1M
Next earnings date	2027-02-22
Price	AUD 0.54
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	asx/OCC
Website	https://orthocell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-9.81%
EV/Sales	9.13x
FCF / EV yield	-13.3%
FCF yield	-9.41%
Industry forward P/E	28.34x
P/B ratio	4.27x
P/S ratio	12.89x
Price / tangible book value	4.37x
Sector forward P/E	33.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-161.15%
EBITDA margin	-155.83%
Gross margin	58.67%
Operating margin	-161.15%
Pretax margin	-121.98%
Profit margin	-121.98%
ROA	-25.52%
ROA (5Y)	-24.26%
ROCE	-39.56%
ROE	-56.82%
ROE (5Y)	-85.37%
ROIC	-45.48%
SBC / revenue	26.44%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	86.83%
Gross profit growth (Q)	112.06%
Gross profit growth 3Y	27.66%
Gross profit growth 5Y	76.36%
Net income growth years	0
Revenue growth	45.37%
Revenue growth (Q)	42.27%
Revenue growth (QoQ)	10.56%
Revenue growth 10Y	32.84%
Revenue growth 3Y	39.05%
Revenue growth 5Y	62.14%
Revenue growth quarters	3
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -1.1M
Depreciation and amortization	AUD 607,521
EBIT	AUD -18.4M
EBITDA	AUD -17.8M
EPS	AUD -0.05
FCF per share	AUD -0.05
Financing cash flow	AUD 30.5M
Free cash flow	AUD -13.8M
Free cash flow minus SBC	AUD -16.9M
Gross profit	AUD 6.7M
Investing cash flow	AUD -37M
Net borrowing	AUD -241,490
Net cash flow	AUD -19.2M
Net income	AUD -13.9M
Operating cash flow minus SBC	AUD -15.8M
Operating income	AUD -18.4M
Revenue	AUD 11.4M
Stock-based compensation	AUD 3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.7
Book value per share	AUD 0.13
Debt / equity	0.03
Long-term assets	AUD 5M
Long-term liabilities	AUD 12.1M
Net cash (debt)	AUD 43M
Net cash / market cap	29.22%
Net cash growth	53.27%
Net debt / equity	-1.25
Piotroski F-Score	3
Property, plant and equipment	AUD 3.3M
Shareholders' equity	AUD 34.4M
Tangible book value	AUD 33.6M
Tangible book value per share	AUD 0.12
Total assets	AUD 54.8M
Total cash	AUD 44M
Total debt	AUD 970,192
Total liabilities	AUD 20.4M
WACC	4.07%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.25
Current assets	AUD 49.8M
Current liabilities	AUD 8.3M
Current ratio	5.97
Inventory turnover	3.26
Net working capital	AUD -2.1M
Quick ratio	5.62
Working capital	AUD 41.5M
Working capital turnover	0.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-17.94%
Shareholder yield	-17.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	21.35%
10Y return CAGR	1.95%
10Y total return	21.35%
150-day SMA	AUD 0.77
1D price change	0.93%
1M price change	-27.03%
1M total return	-27.03%
1W price change	-16.92%
1W total return	-16.92%
1Y price change	-53.25%
1Y return CAGR	-53.27%
1Y total return	-53.25%
20-day SMA	AUD 0.65
200-day SMA	AUD 0.80
3M price change	-23.94%
3M total return	-23.94%
3Y price change	63.64%
3Y return CAGR	17.84%
3Y total return	63.64%
50-day SMA	AUD 0.70
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 1.26
52-week high date	2025-11-03
52-week low	AUD 0.49
52-week low date	2026-10-27
5Y price change	0.93%
5Y return CAGR	0.19%
5Y total return	0.93%
6M price change	-36.47%
6M total return	-36.47%
All-time high	AUD 1.79
All-time high date	2025-02-05
All-time low	AUD 0.11
All-time low date	2019-04-23
Average true range (ATR)	AUD 0.04
Average volume	615.7K
Beta (1Y)	1.32
Beta (2Y)	1.23
Beta (5Y)	-0.03
Change from 52-week high	-56.97%
Change from 52-week low	10.2%
Change from all-time high	-69.83%
Change from all-time low	414.29%
Change from open	-0.92%
Day's gap	1.87%
Dollar volume	AUD 195,560
High price	AUD 0.55
Low price	AUD 0.53
Monthly RSI	38.4
Open price	AUD 0.55
Position in 52-week range	60%
Previous close	AUD 0.54
Price vs 150-day SMA	-29.53%
Price vs 20-day SMA	-16.51%
Price vs 200-day SMA	-32.26%
Price vs 50-day SMA	-23.34%
Relative volume	0.59
RSI	30.91
Sharpe ratio	-1.11
Sharpe ratio (3Y)	0.48
Sharpe ratio (5Y)	0.22
Sortino ratio	-1.61
Sortino ratio (3Y)	0.94
Sortino ratio (5Y)	0.49
Volume	362.1K
Weekly RSI	33.08
YTD price change	-50.23%
YTD total return	-50.23%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	228.5M
Shares change (QoQ)	12.15%
Shares change (YoY)	17.94%
Shares held by insiders	15.63%
Shares held by institutions	4.91%
Shares outstanding	272.4M

Deeper analysis on ASX/OCC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/OCC report

Is a complete ASX/OCC research report available?

No complete published report is available for asx/OCC (ASX/OCC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/OCC (ASX/OCC)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/OCC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/OCC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/OCC

Frequently asked questions